Webinar: Changing FDA Enforcement

Submitted by PersonalCare_admin on March 26, 2010
in
Date : 
April 8, 2010 12:30 to 2:00 PM EDT

Changing FDA Enforcement and its Impact on Cosmetics/OTC Drugs

The Hamburg/Sharfstein-led U.S. Food and Drug Administration (FDA) is substantially re-energizing FDA enforcement and Congress is pushing them hard, which only puts a strong wind at their backs.  Warning letters are up substantially. The Commissioner has told Senator Grassley that she intends to have the FDA increase its use of misdemeanor (non-intent) criminal prosecutions against individuals in positions of corporate responsibility. And imported products are facing ever more scrutiny - limited only by FDA resource constraints. What does all of this mean for manufacturers of cosmetics and cosmetic-drugs? This FDA enforcement webinar will give participants the context for this new enforcement surge and will focus in on areas of particular interest to the cosmetic and cosmetic-drug industry.
 
Don't miss your chance to hear from expert speaker Bob Brady and Joe Levitt of Hogan & Hartson LLP.  Check out the webinar's preliminary agenda.

Questions?  Please contact the Marketing & Member Services Department at 202/331-1770